SCHEMBL9225503

SCHEMBL9225503

O=C1Nc2ccccc2C2(c3cccc(Cl)c3)OCCN12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.47
HTR7 P34969 4/20 0.40
HTR1A P08908 1/20 0.40
HTR2A P28223 1/20 0.40
HTR6 P50406 1/20 0.40
PGR P06401 3/20 0.38
HSD11B1 P28845 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 2/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37
GHSR Q92847 1/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 1/20 0.36
RAF1 P04049 1/20 0.36
TP53 P04637 1/20 0.36
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9231629 0.86 LMNA (0.42) AKR1C3HTR7HTR1AHTR2AHTR6
SCHEMBL9232012 0.85 AKR1C3 (0.56) AKR1C3HTR7HTR1AHTR2AHTR6
SCHEMBL9230546 0.85 LMNA (0.43) AKR1C3HSD11B1MEN1KMT2APOLB
SCHEMBL9230707 0.83 AKR1C3 (0.38) AKR1C3HTR7HTR1AHTR2AHTR6
SCHEMBL9203731 0.82 HTT (0.47) AKR1C3PGRMEN1KMT2APOLB
SCHEMBL9226322 0.81 AKR1C3 (0.38) AKR1C3MEN1KMT2APOLBGAA
SCHEMBL9231114 0.80 AKR1C3 (0.42) AKR1C3HTR7HTR1AHTR2AHTR6
SCHEMBL11843453 0.79 AKR1C3 (0.50) AKR1C3PGRMEN1KMT2AGAA
SCHEMBL11849044 0.79 POLB (0.47) AKR1C3HTR7HTR1AHTR2AHTR6
SCHEMBL11843263 0.78 AKR1C3 (0.51) AKR1C3HTR7HTR1AHTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640087-A1 USE OF TRICYCLIC PYRIMIDINE DERIVATIVES AS ANTI-VIRAL MEDICAMENTS Roche Diagnostics GmbH (DE) 1995-03-01 EP disclosed
WO-1993023405-A1 USE OF TRICYCLIC PYRIMIDINE DERIVATIVES AS ANTI-VIRAL MEDICAMENTS BOEHRINGER MANNHEIM GMBH (DE) 1993-11-25 WO disclosed